SEARCH

SEARCH BY CITATION

References

  • 1
    Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:25602572.
  • 2
    Stamler J, Stamler R, Neaton J. Blood pressure, systolic and diastolic, and cardiovascular risks. Arch Intern Med. 1993;153:598615.
  • 3
    Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142161.
  • 4
    Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895905.
  • 5
    Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011;57:160166.
  • 6
    Hata Y, Muratani H, Kimura Y, et al. Office blood pressure variability as a predictor of acute myocardial infarction in elderly patients receiving antihypertensive therapy. J Hum Hypertens. 2002;16:141146.
  • 7
    Pringle E, Phillips C, Thijs L, et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens. 2003;21:22512257.
  • 8
    Pierdomenico SD, Lapenna D, Di TR, et al. Blood pressure variability and cardiovascular risk in treated hypertensive patients. Am J Hypertens. 2006;19:991997.
  • 9
    Tatasciore A, Zimarino M, Renda G, et al. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res. 2008;31:21372146.
  • 10
    Frattola A, Parati G, Cuspidi C, et al. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993;11:11331137.
  • 11
    National Center for Health Statistics. Plan and operation of the third National Health and Nutrition Examination survey, 1988–1994. US Dept of Health and Human Services Publication 94-1308, Vol. 1. Washington, DC: National Center for Health Statistics; 1994.
  • 12
    Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604612.
  • 13
    Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920929.
  • 14
    KDOQI Working Group. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002;39:S46S75.
  • 15
    Howard SC, Rothwell PM. Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke. Cerebrovasc Dis. 2009;28:331340.
  • 16
    Loria CM, Sempos CT, Vuong C. Plan and operation of the NHANES II Mortality Study, 1992. Vital Health Stat. 1999;38:116.
  • 17
    Harrell FE Jr. Regression Modeling Strategies. New York, NY: Springer; 2001.
  • 18
    Shimbo D, Kuruvilla S, Haas D, et al. Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures. J Hypertens. 2009;27:17751783.
  • 19
    Verdecchia P, Schillaci G, Borgioni C, et al. White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens. 1995;8:790798.
  • 20
    Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000;36:901906.
  • 21
    Parati G, Di RM, Omboni S, et al. Spectral analysis of 24 h blood pressure recordings. Am J Hypertens. 1993;6(6 Pt 2):188S193S.
  • 22
    Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:23682374.
  • 23
    Verdecchia P, Borgioni C, Ciucci A, et al. Prognostic significance of blood pressure variability in essential hypertension. Blood Press Monit. 1996;1:311.
  • 24
    Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5:9398.
  • 25
    Parati G, Saul JP, Di RM, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension. 1995;25:12761286.
  • 26
    Verdecchia P, Angeli F, Gattobigio R, et al. Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. Am J Hypertens. 2007;20:154161.
  • 27
    Chang JJ, Rabinowitz D, Shea S. Sources of variability in blood pressure measurement using the Dinamap PRO 100 automated oscillometric device. Am J Epidemiol. 2003;158:12181226.
  • 28
    Powers BJ, Olsen MK, Smith VA, et al. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011;154:781788.
  • 29
    Skirton H, Chamberlain W, Lawson C, et al. A systematic review of variability and reliability of manual and automated blood pressure readings. J Clin Nurs. 2011;20:602614.